EGCG exposure during pregnancy affects uterine histomorphology in F1 female mice and the underlying mechanisms

Food Chem Toxicol. 2022 Sep:167:113306. doi: 10.1016/j.fct.2022.113306. Epub 2022 Jul 19.

Abstract

Although epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, has been shown to have many benefits, the effect of EGCG exposure in utero on adult uterine development is unclear. In this study, pregnant C57BL/6 mice were exposed to 1 mg/kg body weight (bw) EGCG dissolved in drinking water from gestational days 0.5-16.5. A significant decrease in uterine weight was observed in the adult female mice, accompanied by uterine atrophy, inflammation, and fibrosis in the endometrium. Uterine atrophy was attributed to the thinning of the endometrial stromal layer and a significant reduction in endometrial cell proliferation. The expression levels of related proteins in the NF-κB and RAF/MEK/ERK signaling pathways were significantly increased, which might be responsible for the occurrence of inflammation. Activation of the transforming growth factor beta (TGF-β1)/Smad signaling pathway might be involved in the development of endometrial fibrosis. The changes in the expression of estrogen receptor α, β (ERα, ERβ), progesterone receptor (PGR), and androgen receptor (AR) might lead to changes in the aforementioned signaling pathways. The promoter region methylation level of Esr2 was increased, and the expression of DNMT3A was evaluated. Our study indicates a risk of EGCG intake during pregnancy affecting uterine development in offspring.

Keywords: DNA methylation; EGCG; In utero exposure; Uterine development.

MeSH terms

  • Animals
  • Atrophy
  • Catechin* / analogs & derivatives
  • Catechin* / pharmacology
  • Female
  • Fibrosis
  • Inflammation
  • Mice
  • Mice, Inbred C57BL
  • Pregnancy
  • Tea

Substances

  • Tea
  • Catechin
  • epigallocatechin gallate